MBX Biosciences Inc. Common Stock (MBX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    MBX Biosciences Inc. Comm...

    NASDAQ: MBX · Real-Time Price · USD
    11.55
    -1.37 (-10.60%)
    At close: Sep 05, 2025, 3:59 PM
    11.82
    2.34%
    Pre-market: Sep 08, 2025, 08:20 AM EDT

    MBX Biosciences Common Stock Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 244K 157K 56K
    Gross Profit
    		 -244K -157K -56K
    Operating Income
    		 -68.19M -35.31M -25.16M
    Interest Income
    		 6.27M 2.75M 372K
    Pretax Income
    		 -61.92M -32.56M -26.14M
    Net Income
    		 -61.92M -32.56M -26.14M
    Selling & General & Admin
    		 10.78M 6.78M 3.76M
    Research & Development
    		 57.41M 28.53M 21.4M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 68.19M 35.31M 25.16M
    Interest Expense
    		 n/a n/a 374K
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 68.19M 35.31M 25.16M
    Income Tax Expense
    		 n/a n/a n/a
    Shares Outstanding (Basic)
    		 33.39M 31.85M 31.85M
    Shares Outstanding (Diluted)
    		 33.39M 31.85M 31.85M
    EPS (Basic)
    		 -1.85 -1.02 -0.82
    EPS (Diluted)
    		 -1.85 -1.02 -0.82
    EBITDA
    		 -67.95M -35.15M -25.7M
    EBIT
    		 -68.19M -35.31M -25.76M
    Depreciation & Amortization
    		 244K 157K 56K

    Add to Watchlist